|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/44 | (2006.01) |
| A61P 25/14 | (2006.01) |
| (11) | Number of the document | 2995305 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15172998.5 |
| Date of filing the European patent application | 2012-01-27 | |
| (97) | Date of publication of the European application | 2016-03-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-04 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161437558 P | 2011-01-28 | US |
| (72) |
WESSEL, Thomas C., US
RABINOWICZ, Adrian, L., US
HENEY III, Herbert, R., US
RUNYAN, Jacob, D., US
CAGGIANO, Anthony, US
BLIGHT, Andrew, US
|
| (73) |
Acorda Therapeutics, Inc.,
15 Skyline Drive, Hawthorne, NY 10532,
US
|
| (54) | USE OF POTASSIUM CHANNEL BLOCKERS TO TREAT CEREBRAL PALSY |
| USE OF POTASSIUM CHANNEL BLOCKERS TO TREAT CEREBRAL PALSY |